Found: 11
Select item for more details and to access through your institution.
TGFβ induces SIK to negatively regulate type I receptor kinase signaling.
- Published in:
- Journal of Cell Biology, 2008, v. 182, n. 4, p. 655, doi. 10.1083/jcb.200804107
- By:
- Publication type:
- Article
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 534, p. 1, doi. 10.1126/scitranslmed.aav7431
- By:
- Publication type:
- Article
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 606, doi. 10.1093/jnci/djt054
- By:
- Publication type:
- Article
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.
- Published in:
- Journal of Pathology, 2012, v. 227, n. 4, p. 404, doi. 10.1002/path.4052
- By:
- Publication type:
- Article
Development of a robust flow cytometry-based pharmacodynamic assay to detect phosphoprotein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-76
- By:
- Publication type:
- Article
Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
- Published in:
- Nature, 2014, v. 515, n. 7528, p. 563, doi. 10.1038/nature14011
- By:
- Publication type:
- Article
C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0246486
- By:
- Publication type:
- Article
Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21WAF1/Cip1.
- Published in:
- Journal of Cellular Physiology, 2005, v. 204, n. 1, p. 260, doi. 10.1002/jcp.20304
- By:
- Publication type:
- Article
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
- By:
- Publication type:
- Article